Article
Eribulin Mesylate Targets Human Telomerase Reverse Transcriptase in Ovarian Cancer Cells
6 Nov 2014
Abstract excerpt
Treatment of advanced ovarian cancer involves platinum-based chemotherapy. However, chemoresistance is a major obstacle. Cancer stem cells (CSCs) are thought to be one of the causes of chemoresistance, but the underlying mechanism remains elusive. Recently, human telomerase reverse transcriptase (hTERT) has been reported to promote CSC-like traits. In this study, we found that a mitotic inhibitor, eribulin...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
